Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

Abstract Background Post-transplant lymphoproliferative disorder is a well-recognized but rare complication of hematopoietic stem cell and solid organ transplant. Due to rarity of this disease, retrospective studies from major transplant centers has been the main source to provide treatment guidelin...

Full description

Bibliographic Details
Main Authors: Rohit Bishnoi, Ravneet Bajwa, Aaron J. Franke, William Paul Skelton, Yu Wang, Niraj M. Patel, William Birdsall Slayton, Fei Zou, Nam H. Dang
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Experimental Hematology & Oncology
Subjects:
PTLD
Post-transplant lymphoproliferative disorder
Prognostic factors for PTLD
EBV PTLD
Rituximab for PTLD
Online Access:http://link.springer.com/article/10.1186/s40164-017-0087-0

Internet

http://link.springer.com/article/10.1186/s40164-017-0087-0

Similar Items